Lotus Eye Hospital & Institute Ltd Financials

Lotus Eye Hospital & Institute Ltd Financial Statement

Lotus Eye Hospital & Institute Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	13.18	13.20	11.28
Operating Expense	11.77	11.23	10.13
Net Profit	0.10	0.62	0.02
Net Profit Margin	0.76	4.70	0.18
Earning Per Share	0.05	0.30	0.01
EBIDTA	1.51	1.98	1.10
Effective Tax Rate	7.09	12.18	-6.03

Particulars	Sep 2024
Revenue	13.18
Operating Expense	11.77
Net Profit	0.10
Net Profit Margin	0.76
Earning Per Share	0.05
EBIDTA	1.51
Effective Tax Rate	7.09

Lotus Eye Hospital & Institute Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	48.21	47.04	38.91
Operating Expenses Annual	41.68	39.46	33.06
Operating Profit Annual	7.84	8.73	6.72
Interest Annual	0.10	0.10	0.13
Depreciation	3.73	2.98	2.50
Net Profit Annual	2.91	4.08	2.98
Tax Annual	1.10	1.57	1.11

Particulars	Mar 2024
Total Revenue Annual	48.21
Operating Expenses Annual	41.68
Operating Profit Annual	7.84
Interest Annual	0.10
Depreciation	3.73
Net Profit Annual	2.91
Tax Annual	1.10

Lotus Eye Hospital & Institute Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	9.28	8.79	9.89
Cash Flow from Operations	5.68	4.39	4.41
Cash Flow from Investing	-4.63	-2.19	-3.94
Cash Flow from Financing	-3.40	-1.71	-1.58
Cash Flow at the End	6.93	9.28	8.79

Particulars	Mar 2024
Cash Flow at the Beginning	9.28
Cash Flow from Operations	5.68
Cash Flow from Investing	-4.63
Cash Flow from Financing	-3.40
Cash Flow at the End	6.93

Lotus Eye Hospital & Institute Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	16.47	18.77	17.48
PBIT Margin (%)	8.73	12.44	11.05
PBT Margin (%)	-34.93	-49.74	-41.58
Net PROFIT Margin (%)	6.04	8.67	7.66
Return On Networth / Equity (%)	4.97	7.27	5.55
Return On Networth /Employed (%)	7.06	10.18	7.81
Return On Assets (%)	4.89	7.11	5.44
Total Debt / Equity (X)	0.02	0.02	0.02
Asset Turnover Ratio (%)	0.81	0.82	0.71

Particulars	Mar 2024
PBDIT Margin (%)	16.47
PBIT Margin (%)	8.73
PBT Margin (%)	-34.93
Net PROFIT Margin (%)	6.04
Return On Networth / Equity (%)	4.97
Return On Networth /Employed (%)	7.06
Return On Assets (%)	4.89
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	0.81

Lotus Eye Hospital & Institute Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	48.65	44.18	44.07
Total Current Assets Annual	14.02	14.71	12.87
Non Current Assets Annual	52.61	48.48	48.74
Total Shareholders Funds Annual	59.41	57.58	54.61
Total Assets Annual	66.63	63.19	61.60

Particulars	Mar 2024
Fixed Assets Annual	48.65
Total Current Assets Annual	14.02
Non Current Assets Annual	52.61
Total Shareholders Funds Annual	59.41
Total Assets Annual	66.63

Lotus Eye Hospital & Institute Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Lotus Eye Hospital & Institute Ltd has a market capitalization of 117.52 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Lotus Eye Hospital & Institute Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , Lotus Eye Hospital & Institute Ltd recorded a total revenue of approximately 48.21 Cr marking a significant milestone in the company's financial performance.

Lotus Eye Hospital & Institute Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.1% annually, respectively..

Lotus Eye Hospital & Institute Ltd's current PE ratio is 40.38.

Lotus Eye Hospital & Institute Ltd's ROCE averaged 8.1% from the FY ending March 2022 to 2024, with a median of 7.6%. It peaked at 9.9% in March 2023, reflecting strong capital efficiency over the period..

Lotus Eye Hospital & Institute Ltd's latest EBIT is Rs. 4.11 Cr, surpassing the average EBIT of Rs. 4.69 Cr over the 5 years..